Tillis, Kelly Introduce Bipartisan Legislation to Increase Access to Plasma-Based Medicines
July 24, 2024
July 24, 2024
WASHINGTON, July 24 -- Sen. Thom Tillis, R-North Carolina, issued the following news release:
Today, Senators Thom Tillis (R-NC) and Mark Kelly (D-AZ) introduced the bipartisan Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act, legislation to ensure individuals with rare diseases and immunodeficiencies have access to necessary plasma-based medicines.
"It is critical patients with rare diseases and immunodeficiencies have uninterrupted ac . . .
Today, Senators Thom Tillis (R-NC) and Mark Kelly (D-AZ) introduced the bipartisan Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act, legislation to ensure individuals with rare diseases and immunodeficiencies have access to necessary plasma-based medicines.
"It is critical patients with rare diseases and immunodeficiencies have uninterrupted ac . . .